Alphatec Holdings, Inc. · NASDAQ:ATEC
Alphatec — Merger or Acquisition (October 2006)
16 slides from Alphatec's merger presentation, Oct 2, 2006
Slide 1: Investor Presentation
NASS Investor Presentation September 28, 2006 Seattle, WA
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation and our responses to your questions during the question and answer period will contain our estimated or anticipated future results. These forward-looking statements are typically identified by the words "anticipates," “believes," "expects," "intends," "pl
Slide 3: John Foster, Chairman
John Foster Chairman
Slide 4: Ronald Hiscock, President and CEO
Ronald Hiscock President and CEO
Slide 5: Synergy
Synergy Alphatec Strengths: Infrastructure U.S. Distribution Fusion In-house Manufacturing Custom Engineering Scient’X Strengths: R&D European Distribution Motion Preservation Innovative Products Surgeon Training
Slide 6: Significant Strategic Advantages
Significant Strategic Advantages Together, Alphatec and Scient’X: Service/Technology Combined Largest and Fastest Growing Distribution in 35 Countries Product Portfolio Doubles IP Assets Double
Slide 7: Steve Reinecke, Chief Technology Officer and VP
Steve Reinecke Chief Technology Officer and VP
Slide 8: Synthetics
Synthetics Synthetics Structural Allograft Spacers Structural Allograft Spacers Trauma/Tumor Trauma/Tumor Deformity Deformity Spinal Spacer Spinal Spacer Lumbar Fusion Lumbar Fusion Cervical Fusion Cervical Fusion Posterior Cervical/ Thoracic Fusion Posterior Cervical/ Thoracic Fusion Pending FDA Cl
Slide 9: Cervical Fusion
Cervical Fusion Samarys ® Stella ® DiscoCerv ® PEEK ® Cages : KLA / CC / Olys Isobar ® TTL / SCS Aladyn ® Isolock ® Non-fusion Thoraco- lumbar TeCorp ® Isobar ® TTL
Slide 10: Leading Pure Play in Spinal Implants
Leading Pure Play in Spinal Implants 18 New Products of 26 Total Products Ti Spacer PEEK Spacer Fusion Cervical R&D R&D MIS Manufacturing Disc Arthroplasty R&D R&D Nucleus / Annulus R&D R&D Interspinous Spacer Allograft Biologics R&D Dynamic Stabilization Fusion Lumbar COMBINED = Revenues R & D = Ad
Slide 11: Stephen Hochschuler, M.D., Scientific Advisory Board Chairman
Stephen Hochschuler, M.D. Scientific Advisory Board Chairman (Chairman, Texas Back Institute)
Slide 12: Steve Dixon, Chief Financial Officer and VP
Steve Dixon Chief Financial Officer and VP
Slide 13: ProForma Revenue History
ProForma Revenue History Annual Revenue YE 12/31 ($M) $0 $20 $40 $60 $80 $100 ATEC SX
Slide 14: Transaction Summary
Transaction Summary 74% of Scient’X for $126.7 million – 41% from majority shareholder for stock and cash (85/15) – 33% HealthpointCapital all stock Tender remaining 26% of shares Collar: $5 - $9.50 per share ATEC capital raise Closing timetable Subject to: – Shareholder approval – Fund raising, and
Slide 15: Creating the Largest Independent Spine Company
Creating the Largest Independent Spine Company Questions and Answers
Slide 16: NASS
NASS Investor Presentation Seattle, WA September 2006
Alphatec Holdings — Merger or Acquisition (October 2006) on 6ix